GALNT9 was significantly higher expression in high‐grade serous ovarian cancer,44 and expression of GALNT9 was associated with OS, can be serve as a prognostic marker for personalized therapy of neuroblastoma.45 This evidence concerns the gene GALNT9 and ovarian serous adenocarcinoma.